MedicarePartD.guide

A non-government resource built from CMS public data

2026 Blue Shield Rx Enhanced (PDP) formulary (drug list)

Contract S2468, plan 004 · California · 3,198 drugs on file · formulary ID 00026294. Each drug links to its cost in every CMS PDP Region 32 plan.

Hide drugs on tiers

31 drugs starting with U.

Drug nameTier30-day preferred pharmacy90-day mail orderUsage management
UDENYCA 6 mg/.6mL Injection, SolutionPegfilgrastim-Cbqv5Specialty Tier33%N/A
  • PA
UDENYCA 6 mg/.6mL Injection, SolutionPegfilgrastim-Cbqv5Specialty Tier33%N/A
  • PA
ULTRAMICROSIZE GRISEOFULVIN 125 mg Tablet, CoatedUltramicrosize Griseofulvin Tablets4Non-Preferred Drug37%37%None
ULTRAMICROSIZE GRISEOFULVIN 250 mg Tablet, CoatedUltramicrosize Griseofulvin Tablets4Non-Preferred Drug37%37%None
UNITHROID 100 ug TabletLevothyroxine Sodium3Preferred Brand19%19%None
UNITHROID 112 ug TabletLevothyroxine Sodium3Preferred Brand19%19%None
UNITHROID 125 ug TabletLevothyroxine Sodium3Preferred Brand19%19%None
UNITHROID 137 ug TabletLevothyroxine Sodium3Preferred Brand19%19%None
UNITHROID 150 ug TabletLevothyroxine Sodium3Preferred Brand19%19%None
UNITHROID 175 ug TabletLevothyroxine Sodium3Preferred Brand19%19%None
UNITHROID 200 ug TabletLevothyroxine Sodium3Preferred Brand19%19%None
UNITHROID 25 ug TabletLevothyroxine Sodium3Preferred Brand19%19%None
UNITHROID 300 ug TabletLevothyroxine Sodium3Preferred Brand19%19%None
UNITHROID 50 ug TabletLevothyroxine Sodium3Preferred Brand19%19%None
UNITHROID 75 ug TabletLevothyroxine Sodium3Preferred Brand19%19%None
UNITHROID 88 ug TabletLevothyroxine Sodium3Preferred Brand19%19%None
UPTRAVI 1000 ug Tablet, CoatedSelexipag5Specialty Tier33%N/A
  • PA
  • QL 2 per 1 days
UPTRAVI 1200 ug Tablet, CoatedSelexipag5Specialty Tier33%N/A
  • PA
  • QL 2 per 1 days
UPTRAVI 1400 ug Tablet, CoatedSelexipag5Specialty Tier33%N/A
  • PA
  • QL 2 per 1 days
UPTRAVI 1600 ug Tablet, CoatedSelexipag5Specialty Tier33%N/A
  • PA
  • QL 2 per 1 days
UPTRAVI 200 ug Tablet, CoatedSelexipag5Specialty Tier33%N/A
  • PA
  • QL 2 per 1 days
UPTRAVI 400 ug Tablet, CoatedSelexipag5Specialty Tier33%N/A
  • PA
  • QL 2 per 1 days
UPTRAVI 600 ug Tablet, CoatedSelexipag5Specialty Tier33%N/A
  • PA
  • QL 2 per 1 days
UPTRAVI 800 ug Tablet, CoatedSelexipag5Specialty Tier33%N/A
  • PA
  • QL 2 per 1 days
UPTRAVI TITRATION PACK KitSelexipag5Specialty Tier33%N/A
  • PA
  • QL 2 per 180 days
URSODIOL 250 mg Tablet3Preferred Brand19%19%None
URSODIOL 300 mg Capsule4Non-Preferred Drug37%37%None
URSODIOL 500 mg Tablet3Preferred Brand19%19%None
USTEKINUMAB 45 mg/.5mL Injection, Solution5Specialty Tier33%N/A
  • PA
  • QL 0.5 per 28 days
USTEKINUMAB-AEKN 45 mg/.5mL Injection, Solution4Non-Preferred Drug37%37%
  • PA
  • QL 0.5 per 28 days
USTEKINUMAB-AEKN 90 mg/mL Injection, Solution5Specialty Tier33%N/A
  • PA
  • QL 1 per 28 days

PA = prior authorization, ST = step therapy, QL = quantity limit. Costs are the plan’s initial-coverage cost-sharing from the CMS 2026 formulary files; a drug not listed here is not on this plan’s formulary, though a formulary exception may still be possible.